-
121
-
122
Pulmonary Disease due to Mycobacterium malmoense in British Columbia
Published 1998-01-01“…Cases have, however, rarely been reported from the United States, and, until now, none have been reported in Canada. …”
Get full text
Article -
123
Cellular senescence: from homeostasis to pathological implications and therapeutic strategies
Published 2025-02-01Get full text
Article -
124
-
125
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
Published 2025-01-01Get full text
Article -
126
-
127
-
128
Editorial: Host-diet-microbiome interactions in obesity prevention and treatment
Published 2025-01-01Get full text
Article -
129
Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
Published 2025-01-01Get full text
Article -
130
Vaccines for cancer interception in familial adenomatous polyposis
Published 2025-01-01Get full text
Article -
131
INTERNATIONAL LEGAL FRAMEWORK ON HUMAN TRAFFICKING AND CRIMINAL LIABILITY ON TRAFFICKERS
Published 2023-07-01“…Human trafficking, as recognised in the Declaration of the High-level Meeting on the Rule of Law Trafficking in Persons, preys on the vulnerability of victims and can be considered as a premeditated crime. The United Nations Office on Drugs and Crime (UNODC), as guardian of the United Nations Convention against Transnational Organized Crime (UNTOC) and the Protocols thereto, assists States in their efforts to implement the Protocol to Prevent, Suppress and Punish Trafficking in Persons (Trafficking in Persons Protocol). …”
Get full text
Article -
132
-
133
-
134
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
Published 2025-01-01Get full text
Article -
135
Illegal cannabis cultivation in Europe: new developments
Published 2019-07-01“…This trend in production must be examined against evolving attitudes towards marihuana at the global level, linked especially to new legislation in the United States and in Canada.…”
Get full text
Article -
136
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer’s Disease: A comprehensive review
Published 2022-07-01“…This debilitating disease reportedly consumes 8% of the total United States healthcare expenditure, with medical and nursing outlays accounting for an estimated \$290 billion. …”
Get full text
Article -
137
Human-based complex in vitro models: their promise and potential for rare disease therapeutics
Published 2025-01-01Get full text
Article -
138
-
139
-
140